Researchers have developed a potential diagnostic tool for schizophrenia by observing how patients process conflicting information.

Scientists have known for decades that the classic symptoms of schizophrenia, such as jumping to conclusions or difficulty ...

Researchers have identified a potential diagnostic tool for schizophrenia by measuring brain cell activity between the ...

Two new studies and an accompanying short film have described the experiences of racially minoritized groups with physical and mental health conditions during the pandemic, depicting the inequalities ...

Cobenfy also contains trospium, which blocks some of the side effects. The most common are nausea, vomiting and indigestion.

Most kids with attention issues won't go on to develop serious psychiatric conditions like psychosis or schizophrenia ... much more research is needed to pinpoint precursors to psychotic symptoms ...

On September 26, the U.S. Food and Drug Administration (FDA) approved a drug called Cobenfy to treat schizophrenia. Cobenfy is a combination of xanomeline and trospium chloride that has a novel ...

Which scientific publishers and journals are worst affected by fraudulent or dubious research papers — and which have done least to clean up their portfolio? A technology start-up founded to ...

Scott de Molitor, who suffers from schizophrenia, was found not criminally responsible after Justice Nancy Dilts ruled he was in a psychotic state at the time of the killing and could not ...

A 2012 study found 50% of people with schizophrenia don’t take their prescribed medication, and it’s not just because of side effects. A 2020 research review found we disengage with treatment ...

But the source of deceptive impressions may sometimes be the research papers themselves. For example, researchers may hyper-focus on a limited set of findings. They may fail to report that many of ...